Immunotherapy News and Research

Latest Immunotherapy News and Research

UCLA research points the way towards a longer-lasting COVID vaccine

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

11 Dec 2021

Potentially serious side effect reported after CAR-T cell therapy for multiple myeloma

Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma.

11 Dec 2021

Insight into immune cell communication may pave the way for new cancer vaccines

In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences.

9 Dec 2021

Johns Hopkins astrophysicist receives Life Sciences 2021 award for novel cancer mapping technology

Johns Hopkins astrophysicist, Alexander Szalay, Ph.D., and Kimmel Cancer Center pathologist Janis Taube, M.D., M.Sc., received a Life Sciences 2021 award for AstroPath at this year's Falling Walls Science Summit, an international event honoring research breakthroughs from across the globe.

9 Dec 2021

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

A recent review looks at the molecular design of pH-sensitive cationic lipids and their applications for various tissues and cell types.

7 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach.

7 Dec 2021

Lunaphore highlights novel spatial biology research at SITC 2021

Lunaphore today announced new research from collaborators at the University of Birmingham.

From Lunaphore 7 Dec 2021

Stand Up To Cancer - An Interview with Chris Draft

In this inspiring interview, we speak to former NFL player Chris Draft about lung cancer, and how he has partnered with SU2C to help raise awareness surrounding it.

7 Dec 2021

Novel monoclonal antibody could help revolutionize treatment of children with high-risk neuroblastoma

Survival rates increased about 20% for children with high-risk neuroblastoma enrolled in a St. Jude Children’s Research Hospital clinical trial that included a novel monoclonal antibody produced onsite. The findings appeared today in the Journal of Clinical Oncology.

6 Dec 2021

A faster, safer and more affordable technology to produce personalized cancer therapies

Cell therapy has become an indispensable part of medicine today. With this form of immunotherapy you use your own body cells as medicine to fight the disease.

6 Dec 2021

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

A class of cancer immunotherapy called checkpoint inhibitors has revolutionized cancer treatment. It's a new way to attack the disease by unleashing the immune system.

2 Dec 2021

Penn researchers illuminate key molecular details of T-cell exhaustion process

Specially engineered immune cells called CAR T cells have proven themselves to be a powerful weapon against blood cancers, but against solid tumors they are much less effective, due in part to a process called T-cell exhaustion.

2 Dec 2021

NEI researchers identify unique population of B cells that tamps down the immune system

Researchers at the National Eye Institute (NEI) have identified, isolated, and characterized a unique population of B cells that tamps down the immune system, reducing chronic inflammation.

2 Dec 2021

Advancing our understanding of T cells to improve cancer therapies

In this interview, News-Medical talks to Dr. Brendan Horton about his latest research which has shed new light on cancer and T cells.

2 Dec 2021

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy.

30 Nov 2021

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

With the world still in the grip of a devastating pandemic, it's hard to imagine viruses as something other than hostile enemies to be vanquished.

30 Nov 2021

Johannes Gutenberg University Mainz participates in new Collaborative Research Center

The German Research Foundation has approved the establishment of a new Collaborative Research Center in the field of materials science, in which Johannes Gutenberg University Mainz is participating with a pioneering subproject. In addition, an existing CRC coordinated by JGU was approved for a further funding period of four years.

30 Nov 2021

Treatment with antihistamines associated with improved responses to immunotherapy

New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors.

24 Nov 2021

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

On November 23, 2021, the California Institute for Regenerative Medicine (CIRM) governing board approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.

24 Nov 2021

Immunotherapy News and Research

Latest Immunotherapy News and Research

UCLA research points the way towards a longer-lasting COVID vaccine

Potentially serious side effect reported after CAR-T cell therapy for multiple myeloma

Insight into immune cell communication may pave the way for new cancer vaccines

Johns Hopkins astrophysicist receives Life Sciences 2021 award for novel cancer mapping technology

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

Lunaphore highlights novel spatial biology research at SITC 2021

Stand Up To Cancer - An Interview with Chris Draft

Novel monoclonal antibody could help revolutionize treatment of children with high-risk neuroblastoma

A faster, safer and more affordable technology to produce personalized cancer therapies

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

Penn researchers illuminate key molecular details of T-cell exhaustion process

NEI researchers identify unique population of B cells that tamps down the immune system

Advancing our understanding of T cells to improve cancer therapies

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Review highlights oncolytic viruses with remarkable ability to destroy cancer cells

Johannes Gutenberg University Mainz participates in new Collaborative Research Center

Treatment with antihistamines associated with improved responses to immunotherapy

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in